Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
myosin heavy chain 4 | 0.839 | 0.231 | 1.0E-55 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
peripheral myelin protein 22 | 0.471 | 0.885 | 0.91 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1992 | 1992 | ||||||||
|
neuroligin 3 | 0.653 | 0.462 | 0.98 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
repulsive guidance molecule BMP co-receptor a | 0.656 | 0.692 | 0.16 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
solute carrier family 17 member 7 | 0.636 | 0.308 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
platelet activating factor receptor | 0.575 | 0.731 | 0.24 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
neuroligin 2 | 0.722 | 0.269 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
pleiotrophin | 0.515 | 0.808 | 7.5E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
glutaminyl-tRNA synthetase 1 | 0.716 | 0.231 | 2.7E-13 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
RAN, member RAS oncogene family | 0.576 | 0.808 | 0.98 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
RAN binding protein 1 | 0.736 | 0.615 | 0.82 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
NFKB inhibitor alpha | 0.487 | 0.885 | 0.99 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
nerve growth factor receptor | 0.477 | 0.846 | 9.8E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
neurotensin | 0.517 | 0.769 | 3.9E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
microRNA 381 | 0.584 | 0.654 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
opioid related nociceptin receptor 1 | 0.628 | 0.462 | 0.48 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
regenerating family member 3 alpha | 0.522 | 0.769 | 6.3E-04 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
proprotein convertase subtilisin/kexin type 5 | 0.659 | 0.538 | 2.5E-12 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1998 | 1998 |